Jonathan Dixon V. - 28 Feb 2023 Form 3 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
General Counsel
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
28 Feb 2023
Net transactions value
$0
Form type
3
Filing time
06 Mar 2023, 18:24:45 UTC
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BNGO Common Stock 39,270 28 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BNGO Stock Option (right to buy) 28 Feb 2023 Common Stock 350,000 $2.67 Direct F1
holding BNGO Stock Option (right to buy) 28 Feb 2023 Common Stock 117,810 $1.63 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares shall vest on March 21, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.
F2 The shares vest in 48 equal monthly installments from February 15, 2023 (the "Grant Date").